approved EB-2 (NIW)
Resident Physician
Medical Oncology · 2026-01-09
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Proposed Endeavor
The petitioner proposes to continue analyzing patient-derived tumor tissue to identify biomarkers that guide individualized therapies for solid tumors. This work focuses on translating laboratory discoveries into clinical treatments that maximize efficacy while minimizing harmful side effects for diverse patient populations.
Why This Petition Was Approved
The petition was approved based on a record of 9 peer-reviewed journal articles and 7 abstracts, supported by 92 citations from researchers in oncology and neuroscience. The case successfully demonstrated national importance by aligning with federal goals for early cancer detection and effective treatment of solid tumors.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Government Alignment
Original Contributions
Similar Cases
Project Manager
Biotechnology · India
WeGreened EB-2 (NIW) approved
Alabama 26 days 2024-12-02
The petitioner plans to develop precision biomarker oncology tests for biopsy samples to advance clinical cancer trials and drug development. Her work focuses on elucidating unique characteristics of cancer cells to establish therapeutic targets for precision medicine.
Doctor
Healthcare · China
WeGreened EB-2 (NIW) rfe approved
169 days 2025-06-11
The petitioner proposes to continue his work in personalized oncology by developing tailored treatment regimens based on molecular diagnostics and tumor genomics. His research focuses on refining patient stratification to enable more effective and less toxic cancer therapies.
Postdoctoral Researcher
Biotechnology · Japan
WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
Assistant Professor
Healthcare · Pakistan
WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.
Frequently Asked Questions
A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2026-01-09.
Browse all casesAt a Glance
Outcome approved
Processing 115 days
Evidence Types 4
EB-2 (NIW) Case Data
Scraped Case Data
Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist